West Pharmaceutical Services, Inc.
Price Action
Technical Summary
EMERGING TRENDWest Pharmaceutical Services, Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is moderate (RS Rating: 71), indicating performance broadly in line with the market. Earnings growth of 56% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $285.31 | +9.55% | ABOVE |
| 50 SMA | $261.85 | +19.36% | ABOVE |
| 100 SMA | $259.93 | +20.24% | ABOVE |
| 150 SMA | $264.53 | +18.15% | ABOVE |
| 200 SMA | $260.66 | +19.91% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is WST in an uptrend right now?
WST has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is WST overbought or oversold?
WST's RSI (14) is 72. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is WST outperforming the market?
WST has a Relative Strength (RS) Rating of 71 out of 99. WST is performing about average compared to the market.
Where is WST in its 52-week range?
WST is trading at $312.55, which is 97% of its 52-week high ($322.34) and 92% above its 52-week low ($202.79).
How volatile is WST?
WST has a Beta of 0.92 and 52-week volatility of 41%. It's less volatile than the S&P 500 - generally more stable.